Protocol Calcineurin Inhibitor (CNI) Weaning

Update Il y a 4 ans
Reference: NCT01292525

Woman and Man

  • | Country :
  • France
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The main objective of this study is to demonstrate the benefit of the withdrawal of Tacrolimus (Prograf®) on renal function in patients one year after the end of the weaning period. The secondary objectives will focus on assessing the risks and consequences of withdrawal of Tacrolimus (Prograf®).


Inclusion criteria

  • Function of Renal Transplant

Links